Pulmonary Hypertension Registry: a 10-Year Experience

author

  • ,
Abstract:

Background: Pulmonary Arterial Hypertension (PAH), a fatal orphan disease, is defined as increased mean Pulmonary Arterial Pressure (mPAP) above 25 mm/Hg, Pulmonary Capillary Wedge Pressure (PCWP) below 15 mm/Hg, and pulmonary vascular Resistance over 3 Wood Unit (WU). Although Pulmonary Hypertension (PH) is a relatively prevalent disease, the idiopathic form (iPAH) is a rare disease with a prevalence of 1 to 3 in million population. Methods: The Iranian Registry Program was introduced in 2009 by using its website, www.ipah.ir, for delivery of a standard and national diagnostic protocol to PH patients and also gather patient data in order to provide effective and updated management services to all patients. In this program, the patient data was collected based on guidelines of European Respiratory Society (ERS), European Society of Cardiology (ESC), International Society of Heart and Lung Transplantation (ISHLT), and American College of Cardiology Foundation (ACCF). Moreover, follow up of all patients was possible through the website. Results: 353 PH patients (225 female, 125 male) referred to Masih Daneshvari Hospital Tehran, Iran between 2009-19 and were registered.  Among them 182 patients were characterized as iPAH (n=121 female, n= 61 male). The average age of PH patients was 48.6±16 years for suffering PH and 48.2±15 years for primary idiopathic form. Sparing idiopathic subtype, the aetiology of most PAH patients was Eisen-menger syndrome (43 patients, 12.2%), collagen vascular (22 patients, 6.2%), and chronic thromboembolic pulmonary hypertension (95 patients, 26.9%). Evaluation of functional class based on New York Heart Associated Functional Class (NYHA) showed 15 patients with FC=I (4.6%), 177 patients with FC=II (50.7%), 142 patients with FC=III  (40.7%) and 14 patients with FC=IV (4%). Treatment strategy was Tadafil in 209 patients, Bosentan in 230 and Ilomedin in 65. Due to the economic sanctions in the country, we had limited access to standard medications based on guidelines. Conclusion: Diagnosis, management and follow up of PH and certainly iPAH patients under Iranian PAH Registry System (website www.ipah.ir) during 10 years, leads to organized patient care system and management and also provides invaluable data.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

The Swiss registry for pulmonary arterial hypertension: the paediatric experience.

BACKGROUND Pulmonary arterial hypertension is a rare disease with a poor prognosis. Epidemiological data are scarce, particularly in the paediatric population. A registry was recently developed in order to collect epidemiological data on patients with pulmonary arterial hypertension (PAH) in Switzerland. This is the first description of the paediatric data. METHODS Paediatric patients aged 0-...

full text

Adnexal Masses and Pregnancy: A 10-Year Experience

Background and Objectives: The diagnosis of pregnancy associated adnexal masses is rising due to routine utilization of sonography in prenatal care. The purpose of this study was to describe pregnancy associated adnexal masses over a period of 10 years. Patients and Methods: A retrospective study was reviewed hospital records of all pregnant women with adnexal mass that underwent surgical rese...

full text

EVENTRATION OF THE DIAPHRAGM: A 10- YEAR EXPERIENCE

Eventration of the diaphragm is a condition characterized by an attenuated but otherwise intact diaphragm. Twenty patients (age range: 2 days to 11 years) were treated for eventration of the diaphragm during a ten year period (19 85-1995). There were 11 girls and 9 boys with a mean gestational age of 37 weeks. 14 patients were born with cephalic presentation, 3 patients with breech deliver...

full text

Iranian Pulmonary Arterial Hypertension Registry

BACKGROUND Idiopathic pulmonary arterial hypertension (IPAH) is a fatal disorder with a prevalence of 8.6 per million. We introduce a registry website for IPAH and PAH patients ( www.IPAH.ir) for access and efficient delivery of government-aided and subsidized antihypertensive medications. MATERIALS AND METHODS The IPAH registry was opened in November 2009. Information of IPAH and PAH patient...

full text

PulmoCor: national registry for pulmonary hypertension

Pulmonary hypertension (PH) is a condition that refers to a mean pulmonary artery pressure of at least 25 mmHg measured by right heart catheterisation at rest. PH is classified in five groups based on the underlying clinical condition [1]. Some of these conditions are orphan diseases and managed in designed tertiary PH centres with dedicated multidisciplinary teams. During the last decades grea...

full text

[Choledochal cyst: a 10-year experience]

BACKGROUND: Choledochal cyst is a rare abnormality usually found in infancy and childhood and mainly in females. Outcome depends on early diagnosis, complete resection of the cyst and proper hepaticoenterostomy.OBJECTIVE: The aim of this paper is to evaluate the outcome of 18 patients operated in ten years. METHODS: Retrospective chart review. RESULTS AND DISCUSSION: Age ranged between 20 days ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 37  issue 2

pages  72- 80

publication date 2019-10

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023